Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT05730803

Displacement of Iodine Balance Value During Pregnancy and the Mechanism of Breast Iodine Homeostasis During Lactation

In order to solve the bottleneck problems of"zero balance displacement"and"large variation of breastmilk"in the study of iodine EAR of pregnant women, lactating women and infants, firstly, this study intends to clarify the rate of metabolism and distribution of iodine during pregnancy by 125I tracer, SPECT/CT in vivo small animal imaging and γ counting study. Then, the iodine balance study in rats was conducted to verify the degree of "zero balance value displacement"caused by the difference of iodine absorption and store in different organs and tissues under different iodine exposure levels, so as to determine the iodine selection conditions of subjects in the population experiment. To determine the EAR of pregnant women by optimizing the population iodine balance experiment. Secondly, we proposed to study the regulatory mechanism of NIS and Pendrin in the mammary gland of lactating rats under different iodine nutrition levels to clarify the range of breastmilk iodine compensation. Mammary cell experiments intend to clarify the mutual regulations of iodine nutrition, oestrogen, and NIS and Pendrin. Based on the results of animal and cellular experiments, and the effect of genetic, oestrogen and iodine status were considered, a cross-sectional study of lactating women was conducted to determine the normal reference range of breastmilk iodine after screening out the people with abnormal indicators. This study will solve the bottleneck problems and difficulties in the iodine RNI research for pregnant women, lactating women and infants, found the iodine nutritional compensatory mechanism under special physiology, and provide the scientific basis for obtaining the accurate EAR basic data and the revision of iodine DRIs.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

1 day–40 year

Sex eligibility

Female

Study type

Observational

Primary location

Gansu Provincial Center for Disease Control and Prevention, Lanzhou, China

Loading trial locations.

About this study

In this study, the absorption, distribution, storage and excretion of 125I in rats were observed by small animal imaging technology in vivo, so as to clarify the characteristics of iodine metabolism under different iodine exposure, and provide a basis for optimizing the experimental cycle of iodine balance experiment. The iodine balance experiment of rats during pregnancy was carried out, the iodine storage in different organs was detected to explain the phenomenon of "zero point balance value shift", and the population with iodine nutrition background was determined as the experimental objects in the iodine balance experiment. The optimized iodine balance experiment was further verified in the population, and the iodine EAR of pregnant women was explored to provide reference data for formulating the recommended iodine intake of pregnant women in China in the future. The expression difference of NIS and Pendrin in lactating rats with different iodine nutritional status was used to determine the range of milk iodine compensation. To determine the synergistic and independent effects of iodine level and estrogen on the expression of NIS and Pendrin in lactating mammary gland cells cultured in primary culture. Through a cross-section study of lactating women, the correlation between milk iodine level and NIS, Pendrin gene mutation, iodine exposure level and estrogen was discussed, the phenomenon of "huge milk iodine variation" was explained, the normal reference range of milk iodine was defined, and the basis was laid for further determination of iodine AI and EAR of lactating mothers in 0-6 months. To clarify the steady-state mechanism of iodine metabolism in pregnancy-milk during special physiological periods with different iodine exposure levels, research ideas and related research results can also provide references for the determination of other nutrient requirements.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Pregnant women:

  • Aged 18-40, who have lived in the area for ≥5 year;
  • Single pregnancy;
  • Those who have no special dietary habits;

Lactating woman:

  • Breastfeeding a child;
  • Normal thyroid function during pregnancy;
  • Term delivery (38-42 weeks of gestation);

Exclusion criteria

Pregnant women:

  • Smoking or drinking;
  • Iodized drugs or contrast agents have been used in the past year;
  • A history of thyroid disease, autoimmune disease, endocrine disease, heart disease, chronic disease or family hereditary disease, etc

Lactating woman:

  • A history of thyroid disease, autoimmune disease, endocrine disease, heart disease, chronic disease or family hereditary disease, etc;
  • Iodized drugs or contrast agents have been used;

Treatment and study plan

Dietary Intervention

Other

During the iodine balance period of pregnant women, seaweed was added to lunch on the 4-6 days of the experiment, and the iodine content was about 200 μg.

Primary outcomes

  1. urine iodine concentration

    Time frame: pregnancy 1-40 weeks

    μg/L

  2. Free thyroxine

    Time frame: pregnancy 1-40 weeks

    pmol/L

  3. Free triiodothyronine

    Time frame: pregnancy 1-40 weeks

    pmol/L

  4. Thyroglobulin(TG)

    Time frame: pregnancy 1-40 weeks

    ug/L

  5. Thyroid-stimulating hormone

    Time frame: pregnancy 1-40 weeks

    mIU/L

  6. Salt iodine concentration

    Time frame: pregnancy 1-40 weeks

    μg/day

  7. Urinary iodine excretion

    Time frame: pregnancy 1-40 weeks

    μg/day

  8. Fecal iodine excretion

    Time frame: pregnancy 1-40 weeks

    μg/day

  9. Dietary iodine intake

    Time frame: pregnancy 1-40 weeks

    μg/day

  10. Water iodine intake

    Time frame: pregnancy 1-40 weeks

    ug/day

  11. Thyroid peroxidase antibody

    Time frame: pregnancy 1-40 weeks

    IU/mL

  12. Thyroglobulin antibody

    Time frame: pregnancy 1-40 weeks

    IU/mL

  13. Milk iodine excretion

    Time frame: Postpartum 0-6 months

    μg/day

  14. Milk Iodine concentration

    Time frame: Postpartum 0-6 months

    μg/L

  15. Thyroid volume

    Time frame: Postpartum 0-6 months

    cm³

  16. Na+/I- symporter

    Time frame: Postpartum 0-6 months

    mRNA

  17. Pendrin

    Time frame: Postpartum 0-6 months

    mRNA

  18. estrogen

    Time frame: Postpartum 0-6 months

    pmol/L

  19. progesterone

    Time frame: Postpartum 0-6 months

    pmol/L

  20. oxytocin

    Time frame: Postpartum 0-6 months

    ng/L

  21. prolactin

    Time frame: Postpartum 0-6 months

    pg/MI

Secondary outcomes

  1. Milk output

    Time frame: Postpartum 0-6 months

    μg/day

Study contacts

Contact information is provided by the study sponsor or research team.

Wanqi Zhang, docotorate

CONTACT

[email protected]

022-83336595

Ying Ye

CONTACT

[email protected]

022-83336717

Sponsors and collaborators

Lead sponsor

Tianjin Medical University

Other

Registry information

Official study title

Study on the Displacement of Iodine Balance Value During Pregnancy and the Mechanism of Breast Iodine Homeostasis During Lactation Under Different Iodine Exposure

Important dates

Study start
2023
Primary completion
2027
Study completion
2027
First posted
Feb 16, 2023
Registry last updated
Feb 16, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.